Category: Nanomedicine
Oceania Nanomedicine
-
Nanomedicine Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Indication (Oncology, Infectious Disease, Cardiology, Neurological Disease); By Application (Drug Delivery, Regenerative Medicine, Vaccines, Active Implants); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA))
... America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)) Global Nanomedicine Therapeutics Market Size Booming at CAGR of 9.42% to Surpass Whopping USD 369 Billion by 2030 Global Nanomedicine Therapeutics Market ... Read More
-
Injectable Nanomedicines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global demand for injectable nanomedicines is witnessing significant growth, driven by advancements in nanotechnology that enhance drug safety and efficacy. These nanomedicines are designed to release drugs at targeted sites, allowing for the accumulation of ... Read More
-
Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Australia Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, and Others), Nanomedicine, Cell & Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Middle East and Asia Pacific Biotechnology Market, by Technology (Nanobiotechnology, Tissue Engineering and Regeneration, Fermentation, Cell Based Assay, CRISPR, and Others ), by Application (Molecular Biology, Gene Synthesis, Gene Editing, Mammalian Prot
... Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) ... Read More
-
Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) -
... 2022 - 2028 Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing government ... Read More
-
Middle East and Asia Pacific Biotechnology Market, by Technology (Nanobiotechnology, Tissue Engineering and Regeneration, Fermentation, Cell Based Assay, CRISPR, and Others ), by Application (Molecular Biology, Gene Synthesis, Gene Editing, Mammalian Protein Expression, Recombinant Antibody Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) ... Read More
Research Assistance
